Literature DB >> 15153314

The regulation and activation of CD44 by natural killer (NK) cells and its role in the production of IFN-gamma.

Sarah L Sague1, Cristina Tato, Ellen Puré, Christopher A Hunter.   

Abstract

Natural killer (NK) cells can express high levels of CD44, and signaling through CD44 has been shown to enhance NK cell cytotoxic activity. However, little is known about the factors that regulate CD44-mediated activation of NK cells. The studies reported here reveal that resting NK cells constitutively express CD44 that is in an inactive form that does not bind to hyaluronan (HA), the principal known ligand for CD44. After infection of mice with the intracellular parasite Toxoplasma gondii, however, a population of NK cells that expressed activated CD44 emerged. To determine how expression and activation of CD44 by resting NK cells were regulated, the role of cytokines in these events was assessed. These studies revealed that whereas stimulation of resting NK cells with interleukin-12 (IL-12) or IL-18 caused increased expression of CD44, only IL-2 or IL-15 led to the upregulation and activation of CD44. The cytokine-induced upregulation and activation of CD44 was independent of NK cell proliferation. To determine the functional consequences of CD44 activation, the effects of low molecular weight HA (LMWHA) on the production of interferon-gamma (IFN-gamma) by IL-2-activated NK cells were assessed. These studies showed that HA alone had little effect on the production of IFN-gamma, but when used in combination with IL-2, IL-12, or IL-18, LMWHA was a potent enhancer of IFN-gamma production. Together, these studies indicate an important role for proinflammatory cytokines in the activation of CD44 on NK cells and identify a novel pathway to enhance the ability of activated NK cells to produce IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15153314     DOI: 10.1089/107999004323065093

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  13 in total

1.  Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes.

Authors:  Kutlu G Elpek; Mark P Rubinstein; Angelique Bellemare-Pelletier; Ananda W Goldrath; Shannon J Turley
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

2.  Role of sialidase in Mycoplasma alligatoris-induced pulmonary fibroblast apoptosis.

Authors:  Marguerite E Hunt; Daniel R Brown
Journal:  Vet Microbiol       Date:  2006-10-17       Impact factor: 3.293

3.  Role of CC chemokine receptor 4 in natural killer cell activation during acute cigarette smoke exposure.

Authors:  Valerie R Stolberg; Brian Martin; Peter Mancuso; Michal A Olszewski; Christine M Freeman; Jeffrey L Curtis; Stephen W Chensue
Journal:  Am J Pathol       Date:  2013-12-09       Impact factor: 4.307

4.  LNFPIII/LeX-stimulated macrophages activate natural killer cells via CD40-CD40L interaction.

Authors:  Olga Atochina; Donald Harn
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

5.  Proteome analysis of distinct developmental stages of human natural killer (NK) cells.

Authors:  Maxi Scheiter; Ulrike Lau; Marco van Ham; Björn Bulitta; Lothar Gröbe; Henk Garritsen; Frank Klawonn; Sebastian König; Lothar Jänsch
Journal:  Mol Cell Proteomics       Date:  2013-01-13       Impact factor: 5.911

Review 6.  CD44-dependent inflammation, fibrogenesis, and collagenolysis regulates extracellular matrix remodeling and tensile strength during cutaneous wound healing.

Authors:  Priya Govindaraju; Leslie Todd; Snehal Shetye; James Monslow; Ellen Puré
Journal:  Matrix Biol       Date:  2018-06-09       Impact factor: 11.583

7.  Embryo biosensing by uterine natural killer cells determines endometrial fate decisions at implantation.

Authors:  Chow-Seng Kong; Alexandra Almansa Ordoñez; Sarah Turner; Tina Tremaine; Joanne Muter; Emma S Lucas; Emma Salisbury; Rita Vassena; Gustavo Tiscornia; Ali A Fouladi-Nashta; Geraldine Hartshorne; Jan J Brosens; Paul J Brighton
Journal:  FASEB J       Date:  2021-04       Impact factor: 5.834

Review 8.  The where, when, how, and why of hyaluronan binding by immune cells.

Authors:  Sally S M Lee-Sayer; Yifei Dong; Arif A Arif; Mia Olsson; Kelly L Brown; Pauline Johnson
Journal:  Front Immunol       Date:  2015-04-14       Impact factor: 7.561

Review 9.  The immunological effect of hyaluronan in tumor angiogenesis.

Authors:  Fiorella M Spinelli; Daiana L Vitale; Gianina Demarchi; Carolina Cristina; Laura Alaniz
Journal:  Clin Transl Immunology       Date:  2015-12-04

Review 10.  Revisiting the Prominent Anti-Tumoral Potential of Pre-mNK Cells.

Authors:  Fanny Guimont-Desrochers; Sylvie Lesage
Journal:  Front Immunol       Date:  2013-12-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.